Newspaper Publication for standalone Unaudited financial results for the quarter and half year ended on 30th September, 2026.

LGOIJENBU RKT Jenburkt Pharmaceuticals Limited Regd. Office : UNICORN, 14th Floor, Dattaji Salvi Marg, Off Veera Desai Road, Andheri West, Mumbai 400 053. Phone: 022-67 603 603 Ref. No. JPL/CS/2372/2026 Date: 04'" November, 2026. BSE Ltd. Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400 001. Script Code : 524731 Sub. : Newspapers Publications of Standalone Unaudited Financial Results for the quarter and half year ended on 30" September, 2026. Dear Sir, With reference to our letter No. JPL/CS/2371/2026 dated 03 September, 2026, kindly find enclosed, clippings of following two Newspapers dated 04" September, 2026, containing the Standalone Unaudited Financial Results of the Company for the quarter and half year ended on 30" September, 2026. (1) The Free Press Journal, Mumbai (English) and (2) Navshakti, Mumbai (Marathi). Kindly acknowledge. Thanking you, Yours faithfully, Jenburkt Pharmaceuticals Limited, asfy, ae ce MUMBAD | eh od die a & / * 8% Science hai toh Hope hai 3% Hope hai toh Health hai %@ Health hai toh Happiness hai a Email: info@jenburkt.com www.jenburkt.c om CIN No. L24230MH1985PLC036541 x wea freepressjournalin Se pure Wael vere dane EE STARE PRESS JULIO [ae JE NBURKT PHARMACEUTICALS LIMITED a | CIN: L24230MH1985PL.0030844 WENBI IRKT Registonid Office: UNIGORN, 14th Floor, Dattai Salvi Marg, Off Veera Desai Road, Andheri (West), Mambal-400 053 Delivering Excellence in Lite Sciences @ 022 - 67603603 @& Website: wawjenburkt.com © & -maik investor@jenb STATEOFM UNEAUNDITTE D STANDALONE FINANCIAL RESULTS FOR THE QUARTER AND HALF YEAR ENDED ON 30" SEPTEMBER, 2026 The Board of Ofrectors of the Company, al thelr meoling held on Tueoday, 02° Novernber, 2026 approved the unaudited standalone financial results of the Compafnor yth e quarierand half year ended on 30" Septumber, 2026. ‘The full format of the taancal results of the Company, are available on the Slock Exchange's website al waebeelndia.com and are alse posted on the Garmpany's website af htipss//jonburkt.cominvestersiiinancial-vesulis which can be aocessed by scanning the Quick Response (QR) code. By order of the Board For JENBURKT PHARMACEUTICALS LIMITED {Ashish 0. Bhuta) Place : Mumbai Ghairman & Managing Director Date : 03" November, 2026 {DIN: 00226479} NOTES: The above intimation is In accordance with Regulation 33 read with Regulation 47(1)} of the SEB {Listing Obligation & Breast Roqulraments) Regulations, 2015. se eggs gO = ee © —y “yg ee Whang : eres deere codararesiaysy sf | ENB URKT qiqaimiei p: ghaee , dora, yerdbared ael, wity erate Rett " { the, Stee GviP,i sindg )yo e 048, ‘Delivering Excellence in Life Scienves a (8B Seeds : aww pntamitcom ae < avestergijenburit .cem vo wear, 2096 af ieee Feel i ad aatarey Herat, «% Ake, Wes Tha eee item ime dohen dere oe go waa, ok Teh gee feo ante ad sah erie aie aTereraRign fia Prepeiea iat fee, . afien ria frecde vet faeer wew.beclndiacom 34 Gis wEta trig anf htips:jenburkioomvinvestorsinancialregults Hl deri Sauga earqes aie, O fine Ree Gein) aie was eer ge AES. (aveg d. aT fear ; qe aoe aniererounria farten: o@ TER, 203% (Hangieez thee%) ae pane tea) Bar eed Seeecon ar r Me ea Rca Behe. CS eR CULE e